期刊
PHARMACEUTICAL RESEARCH
卷 28, 期 2, 页码 187-199出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-010-0178-7
关键词
clinical; nanoparticle; oncology; pharmacokinetics; targeting
Nanoparticle approaches to drug delivery for cancer offer exciting and potentially game-changing ways to improve patient care and quality of life in numerous ways, such as reducing off-target toxicities by more selectively directing drug molecules to intracellular targets of cancer cells. Here, we focus on technologies being investigated clinically and discuss numerous types of therapeutic molecules that have been incorporated within nanostructured entities such as nanoparticles. The impacts of nanostructured therapeutics on efficacy and safety, including parameters like pharmacokinetics and biodistribution, are described for several drug molecules. Additionally, we discuss recent advances in the understanding of ligand-based targeting of nanoparticles, such as on receptor avidity and selectivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据